StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

6-(Dimethylamino)-2-fluoro-3-formylbenzonitrile → 6-Dimethylamino-2-fluoro-3-{[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamino]-methyl}-benzonitrile

HRID 885688
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 885688
[CH3:1][N:2]([CH3:14])[C:3]1[C:8]([C:9]#[N:10])=[C:7]([F:11])[C:6]([CH:12]=O)=[CH:5][CH:4]=1.[CH3:15][O:16][C:17]1[N:18]=[C:19]2[C:24](=[CH:25][CH:26]=1)[N:23]=[CH:22][CH:21]=[C:20]2[N:27]1[CH:35]=[C:34]2[C:29]([CH2:30][CH2:31][CH:32]([NH2:36])[CH2:33]2)=[N:28]1.[BH4-].[Na+]>CO.O>[CH3:1][N:2]([CH3:14])[C:3]1[C:8]([C:9]#[N:10])=[C:7]([F:11])[C:6]([CH2:12][NH:36][CH:32]2[CH2:31][CH2:30][C:29]3[C:34](=[CH:35][N:27]([C:20]4[C:19]5[C:24](=[CH:25][CH:26]=[C:17]([O:16][CH3:15])[N:18]=5)[N:23]=[CH:22][CH:21]=4)[N:28]=3)[CH2:33]2)=[CH:5][CH:4]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 27367286-(Dimethylamino)-2-fluoro-3-formylbenzonitrileHCID 4311764Sodium borohydrideHCID 595606482-(6-Methoxy-[1,5]naphthyridin-4-yl)4,5,6,7-tetrahydro-2H-indazol-5-ylamine

Produkt 1

HCID 119483626-Dimethylamino-2-fluoro-3-{[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamino]-methyl}-benzonitrileAusbeute 44 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterKatalysatorHCID 887MethanolLösungsmittel

Versuchsvorschrift

To a solution of 6-dimethylamino-2-fluoro-3-formyl-benzonitrile (69 mg, 0.36 mmol) in CH3OH (7 mL) was added 2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamine (11 mg, 0.34 mmol). The reaction mixture was stirred overnight at RT. NaBH4 (19 mg, 0.50 mmol) was then added and the suspension was stirred for 30 min at RT. The reaction mixture was diluted with a few drops of H2O, and the solvents were removed under reduced pressure. The crude material was purified by basic reverse phase to provide 70 mg (44%) of the title compound. MS (ESI): exact mass calculated for C26H26FN7O, 471.22; m/z found, 472.5 [M+H]+. 1H NMR (500 MHz, CDCl3): 9.09 (s, 1H), 8.75 (d, J=5.1, 1H), 8.26 (d, J=9.1, 1H), 8.14 (d, J=5.1, 1H), 7.38 (t, J=8.7, 1H), 7.18 (d, J=9.1, 1H), 6.58 (d, J=8.7, 1H), 4.75 (br s, 1H), 4.10 (s, 3H), 3.86 (s, 2H), 3.08 (s, 6H), 3.02-2.97 (m, 3H), 2.84-2.77 (m, 1H), 2.52 (dd, J=16.6, 9.9, 1H), 2.15-2.11 (m, 1H).

Aufarbeitung

  1. stirringthe suspension was stirred for 30 min at RT
  2. customthe solvents were removed under reduced pressure
  3. customThe crude material was purified by basic reverse phase

Quellen und Nachweise

ORD-Eintrag
ord-8a30536507bf42a1810b8ebb0acce43a
Quelldatensatz
uspto-grants-2012_08
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08242275B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion